NDC properties for NDC 9 0051-8462
NDC item 00051846201
| NDC 9 | 0051-8462 |
|---|---|
| NDC 10 | 0051-8462-01 |
| NDC Item | 00051846201 |
| packaging | 2.5 g in 1 PACKET |
| DCSA | CIII |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2025-05-01 |
| Marketing effective time low | 2011-04-29 |
| Marketing status | COMPLETED |
| NDA | NDA022309 |
NDC item 00051846230
| NDC 9 | 0051-8462 |
|---|---|
| NDC 10 | 0051-8462-30 |
| NDC Item | 00051846230 |
| packaging | 30 PACKET in 1 CARTON (0051-8462-30) / 2.5 g in 1 PACKET (0051-8462-01) |
| DCSA | CIII |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2025-05-01 |
| Marketing effective time low | 2011-04-29 |
| Marketing status | COMPLETED |
| NDA | NDA022309 |
NDC item 17139056201
| NDC 9 | 17139-562 |
|---|---|
| NDC 10 | 17139-562-01 |
| NDC Item | 17139056201 |
| packaging | 2.5 g in 1 PACKET |
| DCSA | CIII |
| Labeler | ASCEND Therapeutics U.S., LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2023-02-17 |
| Marketing status | ACTIVE |
| NDA | NDA022309 |